Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529

Safety and pharmacokinetics of the non-hormonal male contraceptive YCT-529

Abstract Background Since nearly half of all pregnancies in the US and worldwide are unintended, there is a critical need for additional contraceptive options for men and women. After a hiatus in non-hormonal male contraceptive development of about half a century, the new chemical entity YCT-529 – a...

Full description

Saved in:
Bibliographic Details
Main Authors: Nadja Mannowetz, Stewart W. McCallum, Sharan Sidhu, Karen H. Mena, Eric P. Ruby, Ramiro Castro-Santamaria, Emily Dodds, Dennis Henderson, Gareth Whitaker, Heather Wright, Sarah Beaudoin, Akash Bakshi
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Communications Medicine
Online Access:https://doi.org/10.1038/s43856-025-01004-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s43856-025-01004-4

Similar Items